| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.83B | 4.97B | 4.43B | 1.66B | 55.00M | 0.00 |
| Gross Profit | 121.00M | -1.20B | -2.03B | -3.12B | -465.00M | -29.00M |
| EBITDA | -2.30B | -3.39B | -4.27B | -5.99B | -4.46B | -981.00M |
| Net Income | -3.58B | -4.75B | -5.43B | -6.75B | -4.69B | -1.02B |
Balance Sheet | ||||||
| Total Assets | 15.22B | 15.41B | 16.78B | 17.88B | 22.29B | 4.60B |
| Cash, Cash Equivalents and Short-Term Investments | 7.09B | 7.70B | 9.37B | 11.57B | 18.13B | 2.98B |
| Total Debt | 4.97B | 5.74B | 4.92B | 1.81B | 1.61B | 180.00M |
| Total Liabilities | 10.13B | 8.85B | 7.64B | 4.08B | 2.78B | 5.99B |
| Stockholders Equity | 5.07B | 6.56B | 9.14B | 13.80B | 19.51B | -1.38B |
Cash Flow | ||||||
| Free Cash Flow | -489.00M | -2.86B | -5.89B | -6.42B | -4.42B | -1.76B |
| Operating Cash Flow | 1.08B | -1.72B | -4.87B | -5.05B | -2.62B | -848.00M |
| Investing Cash Flow | -2.89B | -1.98B | -2.51B | -1.37B | -1.79B | -914.00M |
| Financing Cash Flow | 851.00M | 1.14B | 3.13B | 99.00M | 19.83B | 2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.34T | 269.94 | 7.03% | ― | -1.56% | -59.09% | |
65 Neutral | $19.53B | 17.73 | 11.91% | ― | 7.49% | -21.06% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | $18.05B | ― | -65.28% | ― | 28.21% | 44.43% | |
53 Neutral | $23.48B | ― | -9.01% | ― | 86.57% | 51.35% | |
44 Neutral | $13.24B | ― | -329.46% | ― | 9.60% | -5.91% | |
43 Neutral | $4.19B | ― | -61.12% | ― | 45.86% | 22.13% |
On November 6, 2025, Rivian Automotive‘s Board of Directors approved a new performance-based stock option for CEO Dr. Robert J. Scaringe, replacing a previous award from 2021. The new option allows the purchase of up to 36.5 million shares, contingent on achieving significant stock price and financial performance goals, designed to retain and incentivize Dr. Scaringe as Rivian progresses its technology roadmap and launches new products. Additionally, Dr. Scaringe received a profits interest award from Mind Robotics, a subsidiary of Rivian, providing him with a 10% economic interest once certain profit thresholds are met.
The most recent analyst rating on (RIVN) stock is a Hold with a $15.50 price target. To see the full list of analyst forecasts on Rivian Automotive stock, see the RIVN Stock Forecast page.
Rivian’s latest earnings call painted a mixed picture, highlighting both significant achievements and ongoing challenges. The company made notable strides in the development of its R2 program and strategic partnerships, yet it continues to grapple with financial hurdles such as negative automotive gross profit and high adjusted EBITDA losses. While strategic progress is evident, Rivian’s financial challenges remain a concern.
Rivian Automotive, Inc. is an American automotive manufacturer specializing in the development and production of electric vehicles, software, and services that cater to the entire vehicle lifecycle, aiming to redefine the electric vehicle market. In its third-quarter 2025 financial results, Rivian reported a significant 78% increase in consolidated revenue year-over-year, along with a gross profit of $24 million for the quarter. The company also highlighted its progress on the R2 vehicle, which is on track for deliveries in the first half of 2026, and announced an upcoming Autonomy & AI day. Key financial metrics for the quarter include the production of 10,720 vehicles and the delivery of 13,201 vehicles, marking the highest delivery quarter for the year. Automotive revenues rose by 47% to $1,142 million, while software and services revenue surged by 324% to $416 million. Rivian’s gross profit improved by $416 million compared to the previous year, driven by increased selling prices and cost reductions. Looking ahead, Rivian remains focused on scaling its commercial infrastructure and expanding its manufacturing capacity, with plans to create 7,500 jobs at a new facility in Georgia and increase annual production capacity. The company continues to enhance its product offerings and infrastructure, aiming to position itself strongly in the U.S. and European markets.
Rivian Automotive, Inc. announced on October 23, 2025, that it has agreed to settle a securities class action litigation from 2022, which was pending in the United States District Court for the Central District of California. The company, while denying any wrongdoing, has agreed to pay $250 million to resolve the claims, allowing it to focus its resources on the upcoming launch of its mass market R2 vehicle in the first half of 2026. The settlement is subject to court approval and will be funded through a combination of insurance and cash on hand.
The most recent analyst rating on (RIVN) stock is a Sell with a $10.00 price target. To see the full list of analyst forecasts on Rivian Automotive stock, see the RIVN Stock Forecast page.
On October 2, 2025, Rivian announced its production and delivery figures for the quarter ending September 30, 2025, with 10,720 vehicles produced and 13,201 delivered, aligning with its outlook. The company narrowed its 2025 delivery guidance to 41,500 to 43,500 vehicles and plans to release its third-quarter financial results on November 4, 2025, followed by an audio webcast to discuss business performance and outlook.
The most recent analyst rating on (RIVN) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Rivian Automotive stock, see the RIVN Stock Forecast page.